Article
Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.
Journal of clinical microbiology - 1 Apr 2003
Nolte Frederick S, Green Alicia M, Fiebelkorn Kristin R, Caliendo Angela M, Sturchio Cynthia, Grunwald Aileen, Healy Mimi
Abstract excerpt
We compared the performance characteristics of a standardized direct sequencing method (TRUGENE HCV 5'NC; Visible Genetics Inc., Toronto, Ontario, Canada) and a reverse hybridization line probe assay (INNO-LiPA HCV II; Bayer Corp., Tarrytown, N.Y.) for genotyping of hepatitis C virus (HCV). Both methods are based on detection of sequence heterogeneity in the 5' noncoding (5'NC) region. Concordance between the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
